Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 4, 1999, Pages 349-359

  Dockhorn, Robert ^p   Aaronson, Donald ^a   Bronsky, Edwin ^b   Chervinsky, Paul ^c   Cohen, Robert ^d   Ehtessabian, Reza ^e   Finn, Albert ^f   Grossman, Jay ^g   Howland, William ^h   Kaiser, Harold ⁱ   Pearlman, David ^q   Sublett, James ^j   Ratner, Paul ^k   Settipane, Guy ^l   Sim, Tommy ^m   Storms, William ⁿ   Webb, Robert ^q   Drda, Kristin ^o   Wood, Chester ^o  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c St Luke's Hospital   (United States)

^d Allerg and Asthma Clin Res Ctr   (United States)

^e Med Associates Clinic   (United States)

^f Allerg Asthma Centers C   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h HealthQuest Research   (United States)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^j University of Louisville School of Medicine   (United States)

^k HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^l BROWN UNIVERSITY   (United States)

^m University of Texas Medical Branch School of Medicine   (United States)

ⁿ Asthma & Allergy Associates PC and Research Center   (United States)

^o BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^p IMTCI   (United States)

^q NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; IPRATROPIUM BROMIDE; NOSE SPRAY; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; HEADACHE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE CONGESTION; NOSE IRRITATION; PAIN; PERENNIAL RHINITIS; PHARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; RISK BENEFIT ANALYSIS;

EID: 0032963747     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63284-X     Document Type: Article

References (28)

1. Meltzer EO, Orgel HA, Bronsky EA, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effects on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol 1992;90:242-249.
2. Kaiser HB, Findlay SR, Georgitis JW, et al. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. J Allergy Clin Immunol 1995;95:1128-1132.
3. Druce HM, Spector SL, Fireman P, et al. Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis. Ann Allergy 1992;69:53-60.
4. Georgitis JW, Banov C, Boggs PB, et al. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy 1994;24(11):1049-1055.
5. Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol 1995;95:1117-1122.
6. Grossman J, Banov C, Boggs P, et al. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. J Allergy Clin Immunol 1995;95:1123-1127.
7. Wagenmann M, Baroody FM, Jankowski R, et al. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy 1994;24:288-290.
8. Naclerio RM, Baroody FM. In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol 1995;95:1069-1079.
9. Baroody FM, Majchel AM, Roecker MM, et al. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol 1992;89:1065-1075.
10. Wood C, Fireman P, Grossman J, et al. Product characteristics and pharmacokinetics of intranasal ipratropium bromide. J Allergy Clin Immunol 1995;95:1111-1116.
11. Jones LM, Spector SL, English GM, Taylor-Dawson K. Treatment of perennial rhinitis with flunisolide corticosteroid spray. Ann Allergy 1979;42:139-144.
12. Package insert. Flonase® Nasal Spray, 0.05% w/w (fluticasone propionate). In: Physician Desk Reference (PDR) 1996;1098-1100.
13. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988;81:984-991.
14. Juniper EF, and Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83.
15. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36) I. Conceptual framework and item selection. Med Care 1992;30:473-483.
16. 1 antihistamines. Ann Allergy 1991;67:625-633.
17. Borum P, Malm L. Oral vasoconstriction in perennial rhinitis. Allergy 1982;37:67-70.
18. Pakes GE, Brogden HE, Heel RC, et al. Flunisolide: a review of its pharmacologic properties and therapeutic efficacy in rhinitis. Drugs 1980;19:397-411.
19. Scott-Levin Physician Drug and Diagnosis Audit. 1996.
20. Bunnag C, Jareoncharsi E, Wong CKI. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Allergy 1991;47:313-317.
21. Bernstein D, Creticos P, Busse W, et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996;97(3):749-755.
22. Schoenwetter W, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis. Clin Therap 1995;17(3):479-492.
23. Jordana G, Dolovich J, Briscoe M, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97(2):588-595.
24. Bronsky EA, Dockhorn RJ, Meltzer EO, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:915-921.
25. Van Bavel J, Findlay SR, Hampel FC, et al. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-2704.
26. Lau SK, Wei WI, Van Hasselt CA, et al. AQ clinical comparison of budesonide nasal aerosol, terfenadine and a combined therapy of budesonide and oxymetazoline in adult patients with perennial rhinitis. Asian Pacific J Allergy Immunol 1990;8(2):109-115.
27. Fradis M, Podoshin L, Gertner R. Treatment of perennial allergic rhinitis by sodium cromoglycate plus 0.025 per cent xylometazoline (a double-blind study). J Laryngology Otology 1987;101(7):666-672.
28. Simpson RJ. Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Ann Allergy 1994;73:497-502.